US 12,634,129 · Application 19/240,018 · Granted May 19, 2026
US 12,634,129
Multimode heterogeneous iot networks
Estimated expiration
July 22, 2039
12y 320d remaining
Earliest effective filing
Jul 22, 2019
+ 20 years
Jul 22, 2039
PTA +0d
Jul 22, 2039
No TD
—
Final
Jul 22, 2039
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.
Calculation details
Base term
- Filing date
- June 17, 2025
- Earliest effective filing
- July 22, 2019
- Issue date
- May 19, 2026
- PTA
- 0 days
- Base expiry (before PTA)
- July 22, 2039
July 22, 2019 + 20 years = July 22, 2039
- Continuation of application 18/106,497, filed Feb 7, 2023, issued as US 12,348,632
- Continuation of application 16/605,191, filed Oct 14, 2019
- National stage entry of application PCTUS2019042729, filed Jul 22, 2019
- Continuation of application 16/605,191, filed Oct 14, 2019
- PRO62/701,837 — Provisional — not used for base term
- PRO62/701,837 — Provisional — not used for base term
Terminal disclaimers
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 19/240,018 · US 12,634,129
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 12,634,129: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US12634129Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.